Stay updated on Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial

Sign up to get notified when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    External resource links such as MedlinePlus, GARD, PubMed entries, and government/NLM sites were removed from the page.
    Difference
    0.6%
    Check dated 2025-10-27T09:57:56.000Z thumbnail image
  3. Check
    32 days ago
    Change Detected
    Summary
    - Added a government funding notice with status and operating details; updated to Revision: v3.2.0. - Removed Revision: v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T02:01:32.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content, indicating a restructuring and possible narrowing of the domain coverage.
    Difference
    0.4%
    Check dated 2025-09-28T23:34:42.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed. No other core content, pricing, or availability changes were detected.
    Difference
    0.2%
    Check dated 2025-09-14T09:54:28.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T07:45:36.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated to include new resources related to amyotrophic lateral sclerosis (ALS) and has removed some previous content, including specific location details and certain drug information. Notably, the facility name and locations in Hanover, Germany, and Milan, Italy, have been added.
    Difference
    8%
    Check dated 2025-08-31T00:56:42.000Z thumbnail image

Stay in the know with updates to Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety Efficacy TUDCA as add-on Treatment in ALS (TUDCA-ALS) Clinical Trial page.